Largest market shown
Germany
$120.3B calculated opportunity across 62 screened products.
Regional export playbook
Compare buyer markets, access conditions, and product opportunities across Europe. Use this guide to prioritize research, not to treat calculated indicators as guaranteed sales.
Europe regional view
The answer depends on demand, product fit, access, competition, and route economics. This playbook shows where the available trade signals are strongest.
Largest market shown
$120.3B calculated opportunity across 62 screened products.
Regional footprint
Reported trade and access indicators are available for the qualifying markets shown below.
How to use the guide
Start with the strongest markets, then validate buyers, tariffs, standards, logistics, and competition at product level.
Market comparison
Markets are ranked by calculated three-year opportunity across the qualifying products in this regional view.
| Market | Opportunity | Products | FTA | Distance | Entry days | Top product |
|---|---|---|---|---|---|---|
| GermanyDEU | $120.3B | 62 | Reported | 7,265 km | 8 | Petroleum gases and other gaseous hydrocarbons: in gaseous state, natural gas |
| United KingdomGBR | $90.5B | 54 | Reported | 6,784 km | 5 | Vehicles: with only electric motor for propulsion |
| NetherlandsNLD | $58.7B | 28 | Reported | 7,144 km | 4 | Product not reported |
| Switzerland, LiechtensteinCHE | $57.6B | 10 | Not reported | 7,219 km | 10 | Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale |
| FranceFRA | $47.9B | 33 | Reported | 6,882 km | 4 | Aircraft and spacecraft: parts of aeroplanes or helicopters n.e.c. in heading no. 8803 |
| SloveniaSVN | $35.2B | 6 | Reported | 7,749 km | 8 | Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, (other than malonylurea (barbituric acid) and its derivatives),and loprazolam, mecloqualone, methaqualone, zipeprol and salts thereof |
| CzechiaCZE | $23.8B | 15 | Reported | 7,767 km | 25 | Telephones for cellular networks or for other wireless networks |
| BelgiumBEL | $21.9B | 4 | Reported | 7,071 km | 5 | Product not reported |
| ItalyITA | $16.8B | 9 | Reported | 7,573 km | 11 | Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale |
| SwedenSWE | $12.3B | 7 | Reported | 8,069 km | 8 | Oils: petroleum oils and oils obtained from bituminous minerals, crude |
| SpainESP | $8.6B | 7 | Reported | 6,206 km | 13 | Telephones for cellular networks or for other wireless networks |
| IrelandIRL | $7.3B | 6 | Reported | 6,463 km | 11 | Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale |
| AustriaAUT | $7.0B | 7 | Reported | 7,898 km | 21 | Telephones for cellular networks or for other wireless networks |
| PolandPOL | $6.6B | 6 | Reported | 8,231 km | 37 | Product not reported |
| DenmarkDNK | $3.4B | 4 | Reported | 7,702 km | 4 | Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale |
| MaltaMLT | $3.1B | 2 | Reported | 7,748 km | 21 | Commodities not specified according to kind |
| GreeceGRC | $2.3B | 3 | Reported | 8,547 km | 4 | Product not reported |
| NorwayNOR | $1.5B | 1 | Not reported | 7,667 km | 4 | Product not reported |
| UkraineUKR | $1.4B | 1 | Not reported | 8,905 km | 7 | Product not reported |
| CroatiaHRV | $1.0B | 1 | Reported | 7,862 km | 20 | Product not reported |
| LuxembourgLUX | $1.0B | 1 | Reported | 7,170 km | 17 | Product not reported |
| PortugalPRT | $1.0B | 1 | Reported | 5,710 km | 7 | Product not reported |
| RomaniaROU | $965.1M | 1 | Not reported | 0 km | 0 | Product not reported |
| HungaryHUN | $940.1M | 1 | Reported | 8,098 km | 7 | Chemical products, mixtures and preparations: n.e.c. heading 3824 |
| Bosnia and HerzegovinaBIH | $846.8M | 1 | Not reported | 8,057 km | 80 | Product not reported |
| The former Yugoslav Republic of MacedoniaMKD | $810.5M | 1 | Not reported | 8,314 km | 15 | Product not reported |
| FinlandFIN | $691.8M | 1 | Reported | 8,458 km | 13 | Product not reported |
| LatviaLVA | $655.2M | 1 | Reported | 8,418 km | 6 | Product not reported |
| CyprusCYP | $636.4M | 1 | Reported | 9,447 km | 6 | Product not reported |
| Republic of MoldovaMDA | $540.6M | 1 | Not reported | 8,839 km | 4 | Product not reported |
Top regional opportunities
The rows below are screened by reported buyer demand, exporter position, and available history. Calculated opportunity is a research signal, not a forecast.
| Rank | Market | Product | Opportunity | Buyer growth | Current share |
|---|---|---|---|---|---|
| 1 | Switzerland, LiechtensteinCHE | HS 300490Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $27.7B | +12.3% | +0.0% |
| 2 | Switzerland, LiechtensteinCHE | HS 710812Metals: gold, non-monetary, unwrought (but not powder) | $17.3B | +12.8% | +0.0% |
| 3 | GermanyDEU | HS 271121Petroleum gases and other gaseous hydrocarbons: in gaseous state, natural gas | $16.4B | +4.2% | +0.0% |
| 4 | BelgiumBEL | HS 271019Product description unavailable | $12.8B | +9.1% | +0.0% |
| 5 | GermanyDEU | HS 271019Product description unavailable | $12.3B | +5.8% | +0.0% |
| 6 | NetherlandsNLD | HS 271019Product description unavailable | $11.9B | +12.2% | +0.0% |
| 7 | SloveniaSVN | HS 293359Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, (other than malonylurea (barbituric acid) and its derivatives),and loprazolam, mecloqualone, methaqualone, zipeprol and salts thereof | $11.2B | +34.8% | +0.1% |
| 8 | United KingdomGBR | HS 870380Vehicles: with only electric motor for propulsion | $10.2B | +40.0% | +0.0% |
| 9 | GermanyDEU | HS 851712Telephones for cellular networks or for other wireless networks | $9.7B | +9.2% | +0.0% |
| 10 | SloveniaSVN | HS 293399Heterocyclic compounds: n.e.c. in headings no. 2933 | $9.4B | +30.0% | +6.9% |
| 11 | SloveniaSVN | HS 300490Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $9.3B | +17.9% | +3.5% |
| 12 | GermanyDEU | HS 847130Data processing machines: portable, digital and automatic, weighing not more than 10kg, consisting of at least a central processing unit, a keyboard and a display | $8.4B | +3.5% | +0.0% |
| 13 | NetherlandsNLD | HS 847130Data processing machines: portable, digital and automatic, weighing not more than 10kg, consisting of at least a central processing unit, a keyboard and a display | $7.3B | +4.0% | +0.0% |
| 14 | BelgiumBEL | HS 300490Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $7.0B | +8.9% | +0.0% |
| 15 | United KingdomGBR | HS 851712Telephones for cellular networks or for other wireless networks | $6.7B | +7.5% | +0.0% |
| 16 | SwedenSWE | HS 270900Oils: petroleum oils and oils obtained from bituminous minerals, crude | $6.4B | +5.7% | +0.0% |
| 17 | GermanyDEU | HS 851762Communication apparatus (excluding telephone sets or base stations): machines for the reception, conversion and transmission or regeneration of voice, images or other data, including switching and routing apparatus | $6.0B | +11.4% | +0.0% |
| 18 | FranceFRA | HS 880330Aircraft and spacecraft: parts of aeroplanes or helicopters n.e.c. in heading no. 8803 | $5.9B | +6.0% | +0.0% |
| 19 | United KingdomGBR | HS 847130Data processing machines: portable, digital and automatic, weighing not more than 10kg, consisting of at least a central processing unit, a keyboard and a display | $5.7B | +1.9% | +0.0% |
| 20 | CzechiaCZE | HS 851712Telephones for cellular networks or for other wireless networks | $5.5B | +17.1% | +0.0% |
Sector opportunities
HS2 groups make it easier to compare broad product families before moving to individual HS6 products.
HS2 85
50 screened products with $204.6B of reported buyer imports.
$93.7BCalculated opportunity · +8.7% average growthHS2 30
24 screened products with $186.3B of reported buyer imports.
$85.7BCalculated opportunity · +9.5% average growthHS2 00
31 screened products with $203.4B of reported buyer imports.
$85.4BCalculated opportunity · +8.0% average growthHS2 84
39 screened products with $114.7B of reported buyer imports.
$59.6BCalculated opportunity · +5.9% average growthHS2 87
22 screened products with $106.6B of reported buyer imports.
$37.3BCalculated opportunity · +4.4% average growthHS2 71
7 screened products with $114.9B of reported buyer imports.
$27.6BCalculated opportunity · +8.7% average growthHS2 29
4 screened products with $18.4B of reported buyer imports.
$24.5BCalculated opportunity · +28.8% average growthHS2 27
2 screened products with $30.5B of reported buyer imports.
$22.9BCalculated opportunity · +5.0% average growthFrequently asked questions
Practical guidance for interpreting regional market and product comparisons.
Use the market ranking as a starting point, then check product fit, buyer requirements, route costs, tariffs, standards, and competitive conditions.
It is a screening indicator built from demand and exporter-position signals. It is not a confirmed order, sales forecast, or guarantee of market entry.
Prioritize one market and product combination, then validate buyers, compliance, logistics, pricing, and continuity before making a commercial decision.
Data source
OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). OECD BIMTS is the primary trade series for this view. Supporting bilateral trade context uses CEPII BACI bilateral trade flows (202601) under Etalab 2.0 Open Licence. Yugalinks presents derived views of reported observations and calculated indicators. Data terms: OECD Terms & Conditions.